Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078143 · ClinicalTrials.gov registry record · Phase 3
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
A Phase 3 study of Substance-Related Disorders, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 6
- Study locations
NCT00078143: Completed Phase 3 study of Substance-Related Disorders, sponsored by University of Cincinnati.
NCT00078143 is a Phase 3 study of Substance-Related Disorders that has completed, run by University of Cincinnati. The registered enrollment target is 200 participants, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (87% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00078143, a Phase 3 study of Substance-Related Disorders, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.
Conditions Studied
Interventions
- BEHAVIORAL Behavior Therapy
Study Locations (6)
New Mexico
- Milagro Clinic - Albuquerque
- Milagro - Albuquerque
Indiana
- Midtown Community Mental Health Center - Indianapolis
Kentucky
- Jefferson Alcohol & Drug Abuse Center - Louisville
Michigan
- Eleonore Hutzel Recovery Center - Detroit
North Carolina
- Coastal Horizons Center, Inc. - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2003-10 |
| Est. Completion | 2006-04 |
| Phase | Phase 3 |
What the finished NCT00078143 record still lists
NCT00078143 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Behavior Therapy is the first listed.
NCT00078143 lists 6 locations in 5 states (New Mexico, Indiana, Kentucky).
Frequently Asked Questions
What is clinical trial NCT00078143 about?
NCT00078143 is a clinical study titled "Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1". The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.
What is the current status of trial NCT00078143?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2003-10. Estimated completion is 2006-04.
What conditions does trial NCT00078143 study?
This clinical trial studies the following conditions: Substance-Related Disorders.
What interventions are being tested in trial NCT00078143?
The interventions under investigation include: Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00078143?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078143 being conducted?
This trial has 6 study locations across Indiana, Kentucky, Michigan, New Mexico, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00078143's enrollment target sits among peer trials
200 22nd of 58 higher than 36 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
COMPLETED · Phase 3
-
Women's Treatment for Trauma and Substance Use Disorders - 1
COMPLETED · Phase 3
-
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
COMPLETED · Phase 3
-
Job-Seekers Training for Patients With Drug Dependence - 1
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia